Advanced Enzyme Technologies Ltd - Stock Valuation and Financial Performance

BSE: 540025 | NSE: ADVENZYMES | Pharmaceuticals & Drugs | Small Cap

Advanced Enzyme Share Price

345.40 -9.05 -2.55%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Advanced Enzyme

Overall Rating
Bole Toh

1. Quality

2. Valuation

Fair

3. Price Trend

Advanced Enzyme Technologies stock performance -

mw4me loader
P/E Ratio (SA):
31.73
Market Cap:
3,885.9 Cr.
52-wk low:
226.8
52-wk high:
425.1

Is Advanced Enzyme Technologies Ltd an attractive stock to invest in?

1. Is Advanced Enzyme Technologies Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Advanced Enzyme Technologies Ltd is a average quality company.

2. Is Advanced Enzyme Technologies Ltd undervalued or overvalued?

The key valuation ratios of Advanced Enzyme Technologies Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Advanced Enzyme Technologies Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Advanced Enzyme Technologies Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Advanced Enzyme:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Advanced Enzyme Technologies Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 11.8%11.6%11.8%14.3%12.1%11.1%16.4%17.4%11.8%11.1%-
Value Creation
Index
-0.2-0.2-0.20.0-0.1-0.20.20.2-0.2-0.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 136126139173212222247283273312356
Sales YoY Gr.--7.3%10.5%24.1%22.8%4.7%11.4%14.6%-3.8%14.2%-
Adj EPS 1.61.823.13.23.25.26.34.8511
YoY Gr.-13.4%11.2%58.1%1.9%-0.9%64.6%21.7%-24.2%3.3%-
BVPS (₹) 12.714.31622.825.628.332.938.742.94751.4
Adj Net
Profit
17.119.321.634.935.635.358.170.753.755.5122
Cash Flow from Ops. 12.833.522.321.122.635.44684.237.150.3-
Debt/CF from Ops. 4.61.22.21.820.60.2000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 9.7%8%8%14.2%
Adj EPS 13.6%9.2%-1.6%3.3%
BVPS15.7%12.9%12.7%9.5%
Share Price - 13.6% 0.4% 44.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
12.713.213.116.313.111.616.817.611.71122.3
Op. Profit
Mgn %
27.62726.828.423.323.931.535.726.724.427.9
Net Profit
Mgn %
12.615.415.520.216.815.923.52519.717.834.4
Debt to
Equity
0.40.30.30.20.20.10000-
Working Cap
Days
226236224199205234223203230220103
Cash Conv.
Cycle
11714213412511311312010612412682

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 22.30%

Sales growth is good in last 4 quarters at 18.64%

Sales growth has been subdued in last 3 years 7.99%

Net Profit has been subdued in last 3 years -1.56%

Latest Financials - Advanced Enzyme Technologies Ltd.

Standalone Consolidated
TTM EPS (₹) 11 12.3
TTM Sales (₹ Cr.) 356 605
BVPS (₹.) 51.4 115.4
Reserves (₹ Cr.) 553 1,268
P/BV 6.76 3.01
PE 31.73 28.34
From the Market
52 Week Low / High (₹) 226.80 / 425.10
All Time Low / High (₹) 91.05 / 503.00
Market Cap (₹ Cr.) 3,886
Equity (₹ Cr.) 22.4
Face Value (₹) 2
Industry PE 48.2

Management X-Ray of Advanced Enzyme:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Advanced Enzyme

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales136126139173212222247283273312
Operating Expenses 9892103124163169170183200236
Manufacturing Costs19191918191820213034
Material Costs373744628686899699123
Employee Cost 18192427323333343941
Other Costs 24171617263329313238
Operating Profit 373436494953771017375
Operating Profit Margin (%) 27.6%26.8%26.1%28.1%23.3%23.8%31.1%35.6%26.7%24.1%
Other Income 21166697910
Interest 8543331000
Depreciation 987889991010
Exceptional Items -12000000000
Profit Before Tax 10222544444776987274
Tax 135981218271819
Profit After Tax 9192135363558715556
PAT Margin (%) 6.3%15.3%15.0%20.0%16.9%15.9%23.4%25.1%20.0%17.8%
Adjusted EPS (₹)0.81.81.93.13.23.25.26.44.95.0
Dividend Payout Ratio (%)13%6%10%13%16%19%12%14%21%101%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 138156174255286316367433480525
Share Capital 22222222222222222222
Reserves 116134152233264294345410457503
Minority Interest0000000000
Debt4728453340189000
Long Term Debt1651612821000
Short Term Debt3222292132178000
Trade Payables9898211614232018
Others Liabilities 34313221252633343032
Total Liabilities 228222261318373376423490530576

Fixed Assets

Gross Block165167170107114122160174183204
Accumulated Depreciation5562698162433425161
Net Fixed Assets110106101989897127132132143
CWIP 1478107107911
Investments 282753103120120121184189201
Inventories37394751555960638077
Trade Receivables29252331393852554967
Cash Equivalents 212101321825
Others Assets22202825515450465252
Total Assets 228222261318373376423490530576

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 13332221233546843750
PBT 10222544444776987274
Adjustment 1214116973425
Changes in Working Capital -43-9-19-21-6-209-15-13
Tax Paid -5-6-6-10-9-12-13-27-21-16
Cash Flow From Investing Activity -6-7-27-55-22-2-25-70-14-42
Capex -6-4-1-7-7-4-41-9-9-23
Net Investments 0-1-26-50-160-1-63-9-22
Others 0-2132217343
Cash Flow From Financing Activity -7-27434-1-33-19-15-11-12
Net Proceeds from Shares 00047000000
Net Proceeds from Borrowing 0-134-3-4-9-1-200
Interest Paid -4-4-4-3-3-2-1000
Dividend Paid -4-1-30-5-6-8-7-10-11
Others 1-97-811-16-9-7-1-1
Net Cash Flow 0-100002-112-4
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)6.4113.1312.6616.1113.2611.716.9817.7611.9511.05
ROCE (%)9.3813.8414.3118.0615.0714.8521.4524.1615.7814.83
Asset Turnover Ratio0.620.590.620.640.620.590.620.630.540.57
PAT to CFO Conversion(x)1.441.741.050.60.6410.791.180.670.89
Working Capital Days
Receivable Days79735853596366686968
Inventory Days9210410798909387789692
Payable Days132826951637860697957

Advanced Enzyme Technologies Ltd Stock News

Advanced Enzyme Technologies Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Advanced Enzyme on 28-Mar-2024 16:01 is ₹345.4.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Advanced Enzyme stood at ₹3,885.9.
The latest P/E ratio of Advanced Enzyme as of 28-Mar-2024 16:01 is 31.73.
The latest P/B ratio of Advanced Enzyme as of 28-Mar-2024 16:01 is 6.76.
The 52-week high of Advanced Enzyme is ₹425.1 and the 52-week low is ₹226.8.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Advanced Enzyme is ₹355.6 ( Cr.) .

About Advanced Enzyme Technologies Ltd

The company was incorporated as a private limited company on March 15, 1989 under the provisions of the Companies Act, 1956 as Advanced Biochemicals Private Limited in Maharashtra. Pursuant to a special resolution passed by the shareholders of the Company at the extra-ordinary general meeting held on April 21, 1992, the Company was converted into a public limited company and consequently the name of the Company was changed to Advanced Biochemicals Limited. A fresh certificate of change of name reflecting the new name was issued by the Registrar of Companies, Maharashtra on May 28, 1992. Pursuant to a special resolution passed by the shareholders of their Company at the extra-ordinary general meeting held on August 8, 2005, the name of Company was further changed from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited. A fresh certificate of incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra, Mumbai on August 19, 2005.

Advanced Enzymes is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and development, manufacturing and marketing of huge proprietary products developed from various indigenous enzymes & probiotics. The company’s aim is to help consumers’ access side-effect free healthcare, help farmers enhance nutrition for animals, and also to help the industry replace traditional thermal-chemical-mechanical processes into enzyme passed processes.

Business area of the company

The company is a fully integrated enzyme manufacturing company driven by extensive focus on research and development (R&D) of various enzymes, enzyme blends, enzyme products and customized enzyme solutions. Its experienced and qualified R&D team strives to develop creative, cost-effective unique and innovative solutions, thereby enabling their customers to develop superior products and processes. The company products assist its customers in making most of their resources, optimizing their processes, improving their product quality, saving their time and money while also mitigating the impact on the environment. It supplies these value-added and eco-safe enzyme products to diverse end-user industries like human healthcare and nutrition, animal nutrition, food processing, baking, dairy and cheese processing, fruit and vegetable processing, cereal extraction, brewing, grain processing, protein processing, oil and fat processing, biomass processing, textile processing, leather processing, paper & pulp processing, bio-fuels, bio-catalysis etc. Although, the company has the capability to manufacture enzymes using all the four natural origins viz. plant, animal, bacterial and fungal, their major focus is on developing enzymes through microbial fermentation.

Products & Solutions

Human Nutrition: The company’s enzymes are being used by a wide range of customers globally as active ingredients in their pharmaceutical and nutraceutical formulations.

Animal Nutrition: By adding its enzymes to feed, the digestibility of the feed components can be enhanced considerably.

Food Processing: The company’s enzymes play an essential role in bringing more nutrition and appeal to food & beverages products, offering significant benefits beyond the scope of traditional alternatives.

Non-Food Processing: AETL offers eco-safe solutions for a variety of industries such as textiles, leather, detergent, paper & pulp which are used in manufacturing a wide range of products.

Awards

  • 2010: Advanced Enzymes receives Bio-Excellence in Industrial Biotech!
  • 2010: Advanced Enzymes wins the ‘Emerging India Awards 2010’ for Life sciences-Pharmaceuticals & Chemicals segment
  • 2011: Dr. Anil Gupta, General Manager - R&D receives the 2011 Business Leader Award from CHEMTECH foundation
  • 2012: Advanced Enzymes Technologies Limited-received most innovative exporter's award at 'ECGC organized - D&B Indian Exporters Excellence awards.
  • 2013: Advanced Enzymes ranked amongst India’s Fastest-Growing Mid-Sized Cos.
  • 2014: Advanced Enzymes receives Inc. India 500
  • 2014: Advanced Enzymes receives Bio-Excellence in Industrial Biotech
  • 2016: Advanced Enzymes Receives Best Nutraceutical Company of the Year Award
  • 2017: Best IPO Award by IR Society
  • 2018: FE CFO Awards 2018

History and Milestones

  • 1958: Mr. L.C. Rathi sets up India's first enzyme manufacturing plant.
  • 1978: Mr. L.C. Rathi pioneered the production of an enzyme called Papain.
  • 1986L: Acquisition of Super Organic Research Laboratories (SORL) to begin extraction of several commercial enzymes.
  • 1989: Establishment of Rathi Papains Pvt. Ltd. with Mr. L.C.Rathi and Mrs. Savita Rathi as it's founding directors.
  • 1989: Advanced Biochemicals Private Ltd is incorporated to offer global and holistic enzyme solutions.
  • 1991: Advanced Biochemicals commissioned its first fermentation facility at Sinnar, Maharashtra
  • 1992: Advanced Biochemicals is converted from a private company to a public company and renamed as Advanced Biochemicals Limited
  • 1993: Advanced Biochemicals sets up fermentation-based enzyme manufacturing plant with the help of foreign collaboration.
  • 1994: SORL is merged with Advanced Biochemicals Ltd
  • 1996: Advanced Biochemicals sets up a dedicated Application Research facility.
  • 1997: Advanced Biochemicals turns around and reports its first profits.
  • 2001: Advanced Biochemicals' in-house R&D labs at Thane and Sinnar are recognized by the Department of Scientific and Industrial Research (DSIR), Ministry of Science and Technology, Government of India.
  • 2003: Sinnar Factory receives ISO 9001:2000 Systems certification.
  • 2004: Advanced Biochemicals is ranked as the largest domestic manufacturer of Industrial Enzymes.
    Advanced Biochemicals files its first patent.
  • 2005: Advanced Biochemicals Limited is renamed as Advanced Enzyme Technologies Limited (or Advanced Enzymes).
  • 2005: Sinnar Factory receives WHO CGMP certification.
  • 2006: Advanced Enzymes acquires 10 Acre land at Pitampur SEZ near Indore to setup state-of-the-art export oriented facility.
  • 2007: Phase I of the export oriented fermentation facility is completed at Pitampur SEZ near Indore.
  • 2008: Advanced Enzytech Solutions Ltd (Enzytech) is established as a subsidiary of Advanced Enzymes to cover non-food processing divisions.
  • 2009: Advanced Enzyme Far East Ltd., a subsidiary of Advanced Enzymes is dedicated to serving the Chinese market.
  • 2010: Advanced Enzymes is honoured with the 'Emerging India Awards 2010' for Life Science - Pharmaceuticals & Chemicals segment organized by ICICI Business Banking and CNBC TV18.
  • 2010: Advanced Enzymes receives the Bio-Excellence 2010 award as the Best Industrial Biotech Company of the year by the department of IT-BT & ST, Govt. of Karnataka.
  • 2011: Advanced Enzymes expands its presence in the US with the takeover of Cal India Foods International (Specialty Enzymes and Biotechnologies) as a step down subsidiary.
  • 2012: Advanced Enzymes consolidates it presence in the US with the take over of Advanced Supplementary Technologies Corporation as a step down subsidiary.
  • 2012: Advanced Enzymes is awarded 1st runner-up as the Most Innovative Exporter by ECGC - D&B Indian Exporters' Excellence Awards 2012.
  • 2012: Phase II of fermentation facility is inaugurated at Pitampur SEZ near Indore.
  • 2012: Advanced Enzymes receives its first US patent.
  • 2013: Advanced Enzymes is ranked amongst the top 500 as part of Inc. India's fastest-growing mid-sized companies' list for 2012.
  • 2014: Advanced Enzymes has received the Bio-Excellence award for being the Best Industrial Biotech Company at Bangalore India Bio 2014 event - the premier Biotechnology event in the country.
  • 2014: Advanced Enzymes is ranked amongst the top 500 of India’s fastest-growing mid-sized companies list for 2013 by Inc. India.
  • 2016: Conducts IPO & lists itself on the Indian Stock Exchanges.
  • 2016: Acquires majority stake in JC Biotech.
  • 2017: Acquired 100% stake in a German based company evoxx technologies GmbH.
  • 2017: GRAS dossier was filed with USFDA
  • 2018: 4 food enzymes got approved as a processing aid with Food Safety Standard Authority of India (FSSAI)
  • 2018: 4 enzymes are registered with REACH –ECHA (European Chemical Agency)
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.